Project Aim
The aim of this project was to investigate the impact of gene therapy for Leber Congenital Amaurosis (LCA) using a dog model of the disease.
Project Results and Impact
Following gene therapy, the vision impaired dogs showed remarkable improvement in their sight. After this success, the team focused its attention on Age Related Macular Degeneration (AMD).
Professor Rakoczy and her team developed a promising approach called Secretion Gene Therapy to treat wet AMD. Their preclinical trials have shown positive results in inhibiting the growth of harmful blood vessels and maintaining vision. They are now seeking approval to conduct human trials in Australia, with the aim of starting clinical trials soon.
Chief investigator:
Professor Elizabeth Rakoczy
Research at Lions Eye Institute, University of Western Australia
Grant awarded:
$60,000 (2007)
Research Impact Reports
Advancing Usher syndrome type 1B gene therapy with split intein
Project Aim Usher syndrome is the leading cause of combined deafness and blindness in the...
Therapies for currently untreatable autosomal recessive IRDs
Project Aim The project aims to develop new treatments for certain inherited retinal diseases (IRDs)...
Characterizing Stargardt Disease Mutations for Splice Intervention Therapeutics
Project Aim The aim of this project was to find...
Virtual Reality Assessment of Functional Vision in achromatopsia
Project Aim This project aimed to develop and validate a virtual reality (VR) mobility task...